Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 3.02 above is incorporated herein by reference.
Filed Oct 19, 2026Accepted Oct 19, 2026, 4:05 PM EDTCIK 1789192Accession 0001493152-26-047578
We are focused on sustainable operations in various industries such as biotechnology and solar projects. Our activities are advancing innovative drug development solutions through MitoCareX to improve treatments for cancer and inflammatory metabolic diseases.